Utilisation of dense gas technology for the development of controlled release active pharmaceutical ingredients (API) delivery systems

利用致密气体技术开发控释活性药物成分 (API) 输送系统

• 批准号: LP130100826
• 负责人: Em/Prof Neil Foster
• 金额: $ 34.51万
• 依托单位: Curtin University
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-12-15 至 2019-06-30
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP130100826
• 关键词: Utilisation; dense; gas; technology; development

The aim of this project is to develop an orally administered drug formulation for the treatment of irritable bowel syndrome and other diseases of the colon. Irritable bowel syndrome is a debilitating condition and the cost to society is similar to that of asthma. As such, the project has the potential to have a major impact on society.

该项目的目的是开发一种口服药物制剂，用于治疗肠易激综合征和其他结肠疾病。肠易激综合征是一种使人虚弱的疾病，给社会带来的代价类似于哮喘。因此，该项目有可能对社会产生重大影响。